WebDec 29, 2010 · Wednesday, December 29, 2010. Article 69 of the current PRC Patent Law (the “Law”) established the “Patent Exhaustion Doctrine,” providing: “None of the following shall be deemed an ...
China: Experimental Use Exemption Of Patent Infringement
WebJul 19, 2024 · The legislative amendment reflects China’s determination to promote the research and development of innovative drugs in the pharmaceutical industry. ... Patent linkage is established to address the gap between the Bolar Exemption before an MA is issued and patent infringement after the MA is issued. WebJan 19, 2024 · The “Bolar exemption” does not cover the situation where a party offers to sell the patented drugs, has commercially launched them on the market, or the scale of … sunova koers
Patent Exhaustion Doctrine in China The National Law Review
WebOct 3, 2024 · Section 107 (A) of the Patent Law – which is referred to as the ‘Bolar provision’ or ‘Bolar exemption’ – is a safeguard against patent infringement, especially significant to pharmaceutical drugs. The exemption was so named after the landmark US case Roche Products v Bolar Pharmaceuticals, wherein it was held that Bolar’s use of ... WebDec 19, 2024 · Asia-Pacific, European Union December 19 2024. Bolar exemption in Europe. The Bolar exemption is governed by European Directive 2001/83/EC on the … WebThis provision is sometimes called the “regulatory exception” or “Bolar” provision. ... And they agreed to extend exemptions on pharmaceutical patent protection for least-developed countries until 2016. ... Korea, Kuwait, Macao China, Mexico, Qatar, Singapore, Chinese Taipei, Turkey, United Arab Emirates. sunova nz